PPHM Financial Facts
Total costs and expenses: 13.71MResearch and development: 7.76M
See Full Income Statement
Commitments and contingencies: 0
TOTAL ASSETS: 27.02M
See Full Balance Sheet
Peregrine Pharmaceuticals Inc. (PPHM) Earnings
|
Expand Research on PPHM
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -18.8% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | 0.0% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 9/11/17 |  |
Q118 | -$0.06 | -$0.12 | +$0.06 | $27.07M | $15.2M | N/A |  | | Details |
| 7/14/17 | |
Q417 | -$0.16 | N/A | N/A | $17.9M | $18.78M | N/A | | | Details |
| 3/13/17 | |
Q317 | -$0.04 | -$0.03 | -$0.01 | $10.75M | $14M | N/A | | | Details |
12/12/16  |
|
Q217 | N/A | -$0.03 | N/A | $23.37M | $17.98M | N/A | N/A | N/A | |
| 9/8/16 |
|
Q117 | -$0.05 | -$0.04 | -$0.01 | $5.61M | $13.09M | N/A | | | Details |
| 7/14/16 |
|
Q416 | -$0.05 | -$0.03 | -$0.02 | $18.78M | $15.8M | N/A | | | Details |
| 3/9/16 |
|
Q316 | -$0.08 | -$0.07 | -$0.01 | $6.71M | $7.96M | N/A | | | Details |
| 12/10/15 |
|
Q216 | -$0.07 | -$0.09 | +$0.02 | $9.52M | $7.5M | N/A | | | Details |
